MedTrace Logo

Study of Vitamin D in Untreated Metastatic Colorectal Cancer

NCT01516216 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2022-04-26

Study results available
· View outcomes & findings →

Summary

This is a prospective, randomized, double-blind phase II trial to evaluate the efficacy and safety of two doses of vitamin D supplementation in combination with standard chemotherapy in participants with previously-untreated metastatic colorectal adenocarcinoma.

Conditions

Interventions

DRUG

FOLFOX + bevacizumab

DIETARY_SUPPLEMENT

Vitamin D

Sponsors & Collaborators

Principal Investigators

  • Kimmie Ng, MD, MPH · Dana-Farber Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-13
Primary Completion
2019-11-09
Completion
2019-11-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01516216 on ClinicalTrials.gov